Download PDF
Horm Metab Res 2010; 42(5): 353-357
DOI: 10.1055/s-0030-1248298
Humans, Clinical

© Georg Thieme Verlag KG Stuttgart · New York

Antidiabetic Effect of Gynostemma pentaphyllum Tea in Randomly Assigned Type 2 Diabetic Patients[*]

V. T. T. Huyen1 , 2 , 3 , D. V. Phan2 , P. Thang3 , N. K. Hoa1 , 2 , C. G. Östenson1
  • 1Karolinska Institute, Stockholm, Sweden
  • 2Hanoi Medical University, Hanoi, Vietnam
  • 3National Institute of Gerontology, Hanoi, Vietnam
Further Information

Publication History

received 17.08.2009

accepted after second revision 28.01.2010

Publication Date:
08 March 2010 (online)

Also available at
    Permissions and Reprints

Abstract

The aim of the study was to investigate the antidiabetic effect of the traditional Vietnamese herb Gynostemma pentaphyllum in 24 drug-naïve type 2 diabetic patients. All patients were randomized to authenticated Gynostemma pentaphyllum tea or placebo tea, 6 g daily, during twelve weeks and received information regarding diet and exercise. Fasting plasma glucose, insulin levels, and glycosylated hemoglobin (HbA1C) were measured before, during, and after the treatment. Oral glucose tolerance tests were performed every four weeks. After 12-week treatment, fasting plasma glucose levels totally decreased to an extent of 3.0±1.8 mmol/l in the Gynostemma pentaphyllum tea group as compared to a decrease of 0.6±2.2 mmol/l in the control group (p<0.01). HbA1C levels after 12 weeks decreased approximately 2% units in the Gynostemma pentaphyllum group compared to 0.2% unit in the controls (p<0.001). Change in Homeostasis Model Assessment-Insulin Resistance between baseline and twelfth week indicated that insulin resistance decreased significantly in the Gynostemma pentaphyllum group (−2.1±3.0) compared with that (+1.1±3.3) in the control group (p<0.05). There were no hypoglycemias, or adverse effects regarding kidney and liver parameters or gastrointestinal function. In addition, lipid profiles, glucagon, cortisol levels, body measurements, and blood pressure were not different between the groups. This study shows a prompt improvement of glycemia and insulin sensitivity, and thereby provides a basis for a novel, effective, and safe approach, using Gynostemma pentaphyllum tea, to treat type 2 diabetic patients.

Key words

herbal medicine - type 2 diabetes - Gynostemma pentaphyllum tea - insulin sensitivity

1 This study is registered at ClinicalTrial.gov with ID: NCT00786500.*

References

  • 1 King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections.  Diabetes Care. 1998;  21 1414-1431
    Search in Google Scholar
  • 2 Quoc PS, Charles MA, Cuong NH, Lieu LH, Tuan NA, Thomas M, Balkau B, Simon D. Blood glucose distribution and prevalence of diabetes in Hanoi (Vietnam).  Am J Epidemiol. 1994;  139 713-722
    Search in Google Scholar
  • 3 Baumann LC, Blobner D, Binh TV, Lan PT. A training program for diabetes care in Vietnam.  Diabetes Educ. 2006;  32 189-194
    Search in Google Scholar
  • 4 Schwarz PE, Schwarz J, Bornstein SR, Schulze J. Diabetes prevention – from physiology to implementation.  Horm Metab Res. 2006;  38 460-464
    Search in Google Scholar
  • 5 Schwarz PE, Li J, Tuomilehto J. Tools for predicting the risk of type 2 diabetes in daily practice.  Horm Metab Res. 2009;  41 86-97
    Search in Google Scholar
  • 6 Schwarz PE, Muylle F, Valensi P. Diabetes Prevention Forum-IDF Europe . The European perspective of diabetes prevention.  Horm Metab Res. 2008;  40 511-514
    Search in Google Scholar
  • 7 Wolsko PM, Eisenberg DM, Davis RB, Ettner SL, Phillips RS. Insurance coverage, medical conditions, and visits to alternative medicine providers: results of a national survey.  Arch Intern Med. 2002;  162 281-287
    Search in Google Scholar
  • 8 Garrow D, Egede LE. National patterns and correlates of complementary and alternative medicine use in adults with diabetes.  J Altern Complement Med. 2006;  12 895-902
    Search in Google Scholar
  • 9 Saydah SH, Eberhardt M. Use of complementary and alternative medicine among adults with chronic diseases: United States 2002.  J Altern Complement Med. 2006;  12 805-812
    Search in Google Scholar
  • 10 Yeh GY, Eisenberg D, Kaptchuk TJ, Phillips RS. Systematic review of herbs and dietary supplements for glycemic control in diabetes.  Diabetes Care. 2003;  26 1277-1294
    Search in Google Scholar
  • 11 Wang E, Wylie-Rosett J. Review of selected Chinese herbal medicines in the treatment of type 2 diabetes.  Diabetes Educ. 2008;  34 645-654
    Search in Google Scholar
  • 12 Angell M, Kassirer JP. Alternative Medicine-the risks of untested and unregulated remedies.  N Engl J Med. 1998;  339 839-841
    Search in Google Scholar
  • 13 Hoey J. The arrogance of science and the pitfalls of hope.  CMAJ. 1998;  159 803-804
    Search in Google Scholar
  • 14 Ernst E. Herbal medicines: where is the evidence?.  BMJ. 2000;  321 395-396
    Search in Google Scholar
  • 15 Anonymous. Complementary medicine: time for critical engagement.  Lancet. 2000;  356 2023
    Search in Google Scholar
  • 16 Dalen JE. “Conventional” and “unconventional” medicine: can they be integrated?.  Arch Intern Med. 1998;  158 2179-2181
    Search in Google Scholar
  • 17 Fontanarosa PB, Lundberg GD. Alternative medicine meets science.  JAMA. 1998;  280 1618-1619
    Search in Google Scholar
  • 18 Hoa NK, Phan DV, Thuan ND, Ostenson CG. Screening of the hypoglycemic effect of eight Vietnamese herbal drugs.  Methods Find Exp Clin Pharmacol. 2009;  31 165-169
    Search in Google Scholar
  • 19 Norberg A, Hoa NK, Liepinsh E, Phan DV, Thuan ND, Jörnvall H, Sillard R, Ostenson CG. A novel insulin-releasing substance, phanoside, from the plant Gynostemma pentaphyllum.  J Biol Chem. 2004;  279 41361-41367
    Search in Google Scholar
  • 20 Hoa NK, Norberg A, Sillard R, Phan DV, Thuan ND, Dzung DT, Jörnvall H, Ostenson CG. The possible mechanisms by which phanoside stimulates insulin secretion from rat islets.  J Endocrinol. 2007;  192 389-394
    Search in Google Scholar
  • 21 Megalli S, Davies NM, Roufogalis BD. Anti-hyperlipidemic and hypoglycemic effects of Gynostemma pentaphyllum in the Zucker fatty rat.  J Pharm Sci. 2006;  9 281-291
    Search in Google Scholar
  • 22 Department of Material Medica, Hanoi College of Pharmacy. . Textbook of Material Medica. 2006;  1 36-38
  • 23 Department of Material Medica, Hanoi College of Pharmacy. . Guideline of Material Medica practice. 2006;  1 16-17
  • 24 World Health Organization. .WHO, Definition, Diagnosis, and Classification of Diabetes Mellitus and Its Complications: Report of a WHO Consultation, Part 1: Diagnosis and Classification of Diabetes Mellitus.. Geneva; 1999
    Search in Google Scholar
  • 25 Herbert V, Lau KS, Gottlieb CW, Bleicher SJ. Coated charcoal immunoassay of insulin.  J Clin Endocrinol Metab. 1965;  25 1375-1384
    Search in Google Scholar
  • 26 Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.  Diabetologia. 1985;  28 412-419
    Search in Google Scholar
  • 27 Roghani M, Baluchnejadmojarad T. Hypoglycemic and hypolipidemic effect and antioxidant activity of chronic epigallocatechin-gallate in streptozotocin-diabetic rats.  Pathophysiology. 2010;  17 55-59
    Search in Google Scholar
  • 28 Nahas R, Moher M. Complementary and alternative medicine for the treatment of type 2 diabetes.  Can Fam Physician. 2009;  55 591-596
    Search in Google Scholar
  • 29 Tsuneki H, Ishizuka M, Terasawa M, Wu JB, Sasaoka T, Kimura I. Effect of green tea on blood glucose levels and serum proteomic patterns in diabetic (db/db) mice and on glucose metabolism in healthy humans.  BMC Pharmacol. 2004;  4 18
    Search in Google Scholar
  • 30 Davidson MB, Peters AL. An overview of metformin in the treatment of type 2 diabetes mellitus.  Am J Med. 1997;  102 99-110
    Search in Google Scholar
  • 31 Attawish A, Chivapat S, Phadungpat S, Bansiddhi J, Techadamrongsin Y, Mitrijit O, Chaorai B, Chavalittumrong P. Chronic toxicity of Gynostemma Pentaphyllum.  Fitoterapia. 2004;  75 539-551
    Search in Google Scholar
  • 32 Lu KW, Tsai ML, Chen JC, Hsu SC, Hsia TC, Lin MW, Huang AC, Chang YH, Ip SW, Lu HF, Chung JG. Gypenosides inhibited invasion and migration of human tongue cancer SCC4 cells through down-regulation of NFkappaB and matrix metalloproteinase-9.  Anticancer Res. 2008;  28 ((2A)) 1093-1099
    Search in Google Scholar
  • 33 Chen JC, Lu KW, Lee JH, Yeh CC, Chung JG. Gypenosides induced apoptosis in human colon cancer cells through the mitochondria-dependent pathways and activation of caspase-3.  Anticancer Res. 2006;  26 ((6B)) 4313-4326
    Search in Google Scholar
  • 34 Chou SC, Chen KW, Hwang JS, Lu WT, Chu YY, Lin JD, Chang HJ, See LC. The add-on effects of Gynostemma pentaphyllum on nonalcoholic fatty liver disease.  Altern Ther Health Med. 2006;  12 34-39
    Search in Google Scholar
  • 35 Lin CC, Huang PC, Lin JM. Antioxidant and hepatoprotective effects of Anoectochilus formosanus and Gynostemma pentaphyllum.  Am J Chin Med. 2000;  28 87-96
    Search in Google Scholar
  • 36 Huang WC, Kuo ML, Li ML, Yang RC, Liou CJ, Shen JJ. Extract of Gynostemma pentaphyllum enhanced the production of antibodies and cytokines in mice.  Yakugaku Zasshi. 2007;  127 889-896
    Search in Google Scholar
  • 37 Rujjanawate C, Kanjanapothi D, Amornlerdpison D. The anti-gastric ulcer effect of Gynostemma pentaphyllum Makino.  Phytomedicine. 2004;  11 431-435
    Search in Google Scholar
  • 38 Hesse C, Razmovski-Naumovski V, Duke CC, Davies NM, Roufogalis BD. Phytopreventative effects of Gynostemma pentaphyllum against acute Indomethacin-induced gastrointestinal and renal toxicity in rats.  Phytother Res. 2007;  21 523-530
    Search in Google Scholar
  • 39 Hung TM, Hoang DM, Kim JC, Jang HS, Ahn JS, Min BS. Protein tyrosine phosphatase 1B inhibitory activity by dammaranes from Vietnamese Giao-Co-Lam tea.  J Ethnopharmacol. 2009;  124 240-245
    Search in Google Scholar

1 This study is registered at ClinicalTrial.gov with ID: NCT00786500.*

Correspondence

V. T. T. Huyen

Claes-Göran Östenson

Department of Molecular Medicine & Surgery

Endocrine & Diabetes Unit

Karolinska Institute

Karolinska University Hospital

17176 Stockholm

Sweden

Phone: +46/8/51776200

Fax: +46/8/51773096

Email: huyen.vu@ki.se

Email: claes.ostensson@karolinska.se